Trump Cancels Alzheimer's Study Amid Criticism
· diy
Canceling Science: The Trump Administration’s Attack on Medical Research
The cancellation of research grants under the Trump administration has become a disturbing pattern. Hundreds of medical studies, including one examining Alzheimer’s disease in minority communities, have been terminated. This is not just about lost funding; it’s an attack on the integrity and diversity of science.
Roderick Blair, a 70-year-old retired emergency preparedness worker from Pittsburgh, was part of the Phresh study, which aimed to understand how food deserts affect cognitive health in low-income Black neighborhoods. For over a decade, Blair provided data on his habits, biometrics, and life experiences, including taking cognitive tests. However, the study was terminated prematurely by the Trump administration.
The cancellation has significant implications for understanding Alzheimer’s disease, particularly among minority communities. Research shows that Black Americans are nearly twice as likely to develop Alzheimer’s dementia compared to their white counterparts. Studies like Phresh were crucial in shedding light on social determinants of this disparity – factors such as neighborhood divestment, trauma, and systemic racism.
The Trump administration has framed the cancellations as a response to “unscientific” research, but these studies are vital for advancing medical knowledge and addressing health disparities in underserved communities. The Phresh study was designed to capture the unique experiences and challenges faced by Black Americans living in food deserts.
Researchers were given only 90 days to shut down the study, an impossible timeline for conducting cognitive adjudications – a crucial step in interpreting results. This delay not only stymied diagnosis but also hindered the development of targeted interventions.
The cancellation of grants like Phresh is part of a broader pattern of targeting and undermining research that challenges the administration’s ideology or serves marginalized communities. This has significant implications for public health, education, and social justice. As Blair noted, “If you don’t agree with me, you’re going to go to the woodshed.”
The impact of these actions will be felt long after Trump leaves office. Researchers rely on sustained funding to continue their work, and the loss of data, expertise, and momentum can have devastating consequences for public health and medical progress.
As the nation grapples with pressing issues like COVID-19, climate change, and Alzheimer’s disease, it’s crucial that we prioritize evidence-based research and policy-making. The cancellation of grants like Phresh sends a chilling message to researchers: their work is not valued or respected unless it aligns with the administration’s priorities.
The Trump administration’s attack on medical research is a clear indication of its disregard for science, diversity, and inclusivity. As we move forward, we must recognize the importance of preserving scientific integrity, promoting diversity in research, and supporting communities that have been historically marginalized and underserved.
Roderick Blair’s words are haunting: “What has this administration done that has not been a retribution?” The cancellation of grants like Phresh is a stark reminder of the consequences of politicizing science.
Reader Views
- DHDale H. · weekend handyperson
The Trump administration's cancellation of medical research grants is nothing short of baffling. What really gets my goat is that these studies are often the result of years of collaboration between scientists and community members. In this case, researchers were given an unrealistic 90-day deadline to shut down the Phresh study, which makes it impossible to accurately interpret results. I'd like to see more attention paid to the long-term consequences of abruptly cutting off research funding – not just for the immediate projects, but also for the scientists who've dedicated their careers to finding cures and treatments.
- BWBo W. · carpenter
This cancellation of the Phresh study is more than just politics - it's a blow to community-based research that actually gets results on the ground. These studies aren't just ivory tower exercises; they're built from real people's lives and struggles. By axing projects like Phresh, the Trump administration is not only stalling progress on Alzheimer's but also ignoring the fact that Black Americans face unique environmental and socioeconomic challenges that contribute to the disease's disproportionate impact on their communities.
- TWThe Workshop Desk · editorial
The Trump administration's assault on medical research isn't just about slashing funding, it's about silencing marginalized voices and burying crucial findings. The cancelled Phresh study was a prime example of how research can be a powerful tool for social justice. By ignoring the unique experiences of Black Americans living in food deserts, policymakers are essentially perpetuating the status quo – a status quo that disproportionately burdens already vulnerable communities with preventable disease. We need to hold our leaders accountable not just for their budgets, but also for their commitment to equity and public health.